Q1 2027 Aster DM Quality Care Ltd Earnings Call Transcript
Key Points
- Strong Q1 FY27 performance with revenue up 20% YoY to INR2,597 crores and EBITDA up 30% YoY to INR576 crores, with margin expansion of 170 bps to 22.2%.
- Successful merger integration with zero operational friction and service disruption, bringing together 39 hospitals and 45,000 employees under a unified platform.
- Robust growth in high-acuity specialties, with robotic volumes up 80%, joint replacements up 39%, and transplants up 19% YoY.
- Emerging hospitals segment showed highest growth at 63% YoY, with EBITDA margins more than doubling to 12.4%, and the new Castle Gold facility achieved EBITDA breakeven within nine months.
- Clear expansion roadmap to add 4,170 beds over the next 3-4 years, with 53% brownfield, reducing execution risk and enhancing ROCE.
- One-time exceptional expense of INR114 crores related to merger costs impacted reported PAT, though normalized PAT grew 39% YoY.
- Medical value travel (MVT) contribution remains low compared to peers, though growing at 62% YoY, indicating a need for catch-up.
- Karnataka and Maharashtra growth was slower than company average due to past doctor attrition and competitive pressures, though recovery is underway.
- Net debt at combined level stands at INR1,162 crores, with Quality Care carrying INR1,673 crores debt, which may increase financial leverage.
- Management refrained from providing specific FY27 margin guidance, citing a 2-3 year timeline to reach 24-25% EBITDA margins, which may create uncertainty for investors.
Good evening ladies and gentlemen and a warm welcome to everyone joining us today for the inaugural earnings conference call of Aster DM Quality Care Limited for the first quarter ended June 30, 2026.
Today marks an exciting step forward as we bring together two healthcare leaders into a unified platform.
To discuss our operational and financial performance for Q1 FY 27, we are joined today by the Senior Management Team of. Aster DM Quality Care Dr. Azad Moopan, Executive Chairman Ms. Alisha Moopan, Executive Director Mr. Varun Khanna, MD and Group CEO Designate Mr. Sunil Kumar, Group Chief Financial Officer Before we begin, I would like to remind everyone that some statements made on today's call may be forward-looking in nature and are subject to risks and uncertainties.
I would now like to request our Executive Chairman, Dr. Azad Moopan, to share his opening remarks. Over to you, sir.
()- -
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
